-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
GlobeStar Therapeutics Corp quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q4 2011 to Q4 2023.
- GlobeStar Therapeutics Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending December 31, 2023 was $42.8K, a 5.68% increase year-over-year.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $199K, a 39.1% decline from 2022.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2022 was $327K, a 51.6% decline from 2021.
- GlobeStar Therapeutics Corp annual Net Cash Provided by (Used in) Financing Activities for 2021 was $676K, a 204% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)